John Trusheim

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Egfrviii-expressing Glioblastoma, Neuro-oncology, Act Iv +10

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 528 citations · Full text

Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Linda M. Liau, Keyoumars Ashkan, Steven Brem et al. · JAMA Oncology · 2022 · 356 citations · Full text

Ongoing Clinical Trials

Joanna Clarke, Marguerite Ennis, Kathleen R. Lamborn et al. · Neuro-Oncology · 2010 · 22 citations · Full text

Clinical Trial Management, Clinical Endpoint, Clinical Trials +5

Carboplatin-associated Cranial Neuropathy

Shanlee M. Stevens, Collin M. McClelland, John Trusheim et al. · Neuro-Ophthalmology · 2018 · 15 citations · Full text

Peripheral Nerve Injury, Corticobasal Degeneration, Neurological Disorder +17